Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Approach to elucidate the effect of ketamine on treatment resistant depression (AKD)
jRCTs021190007Recruiting
- Start
- Nov 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Single-arm trial of ketamine in treatment-resistant depression (TRD). Primary endpoint: effect of ketamine on refractory depression. Started Nov 2019; status: recruiting.
02
Drugs
ketamine
03
Conditions
treatment-resistant depression (TRD)
Beyond the preview
Go deeper on jRCTs021190007.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs021190007.